Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones
Protocol ID
AALL1631
Disease (Sub Disease)
Leukaemia (ALL)
Diagnosis Stage
New diagnosis
Location
NSW, QLD, WA
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
EsPhALL network I-BFM Study Group
Trial Status
Open
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Christchurch Hospital
Starship Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
1 year to 21 years at diagnosis
International registry ID's
NCT03007147
Back to Registry
Study Title International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones
Protocol ID AALL1631
Disease (Sub Disease) Leukaemia (ALL)
Diagnosis Stage New diagnosis
Location NSW / QLD / WA
Sponsor Children's Oncology Group
Collaborators National Cancer Institute (NCI)/ EsPhALL network I-BFM Study Group
Links https://clinicaltrials.gov/ct2/show/NCT03007147
Trial Status Open
Trial Open Date 19/04/2018
Sites The Children's Hospital at Westmead / John Hunter Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Christchurch Hospital / Starship Hospital/
Study Type Treatment
Phase Phase 3
Age Eligibility 1 year to 21 years at diagnosis
International registry ID's NCT03007147